163 related articles for article (PubMed ID: 33290871)
1. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome.
Yamazoe E; Fang JY; Tahara K
Int J Pharm; 2021 Jan; 593():120148. PubMed ID: 33290871
[TBL] [Abstract][Full Text] [Related]
2. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
4. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake.
Li X; Chen D; Le C; Zhu C; Gan Y; Hovgaard L; Yang M
Int J Nanomedicine; 2011; 6():3151-62. PubMed ID: 22163166
[TBL] [Abstract][Full Text] [Related]
5. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
Akbari A; Lavasanifar A; Wu J
Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.
Tahara K; Nishio M; Takeuchi H
Drug Dev Ind Pharm; 2018 Apr; 44(4):608-614. PubMed ID: 29166794
[TBL] [Abstract][Full Text] [Related]
7. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
8. Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes.
Ma Q; Han Y; Chen C; Cao Y; Wang S; Shen W; Zhang H; Li Y; van Dongen MA; He B; Yu M; Xu L; Banaszak Holl MM; Liu G; Zhang Q; Qi R
Mol Pharm; 2015 Mar; 12(3):665-74. PubMed ID: 25587935
[TBL] [Abstract][Full Text] [Related]
9. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Anderski J; Mahlert L; Mulac D; Langer K
Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
[TBL] [Abstract][Full Text] [Related]
10. Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI).
Yu T; Chan KW; Anonuevo A; Song X; Schuster BS; Chattopadhyay S; Xu Q; Oskolkov N; Patel H; Ensign LM; van Zjil PC; McMahon MT; Hanes J
Nanomedicine; 2015 Feb; 11(2):401-5. PubMed ID: 25461289
[TBL] [Abstract][Full Text] [Related]
11. Effect of surface charge, particle size, and modification by polyethylene glycol of liposomes on their association with Caco-2 cells across an unstirred water layer.
Kono Y; Iwasaki A; Fujita T
Pharmazie; 2018 Jan; 73(1):3-8. PubMed ID: 29441943
[TBL] [Abstract][Full Text] [Related]
12. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder.
Kaldybekov DB; Tonglairoum P; Opanasopit P; Khutoryanskiy VV
Eur J Pharm Sci; 2018 Jan; 111():83-90. PubMed ID: 28958893
[TBL] [Abstract][Full Text] [Related]
14. Mushroom-brush transitional conformation of mucus-inert PEG coating improves co-delivery of oral liposome for intestinal metaplasia therapy.
Wu Y; Wang W; Yu Z; Yang K; Huang Z; Chen Z; Yan X; Hu H; Wang Z
Biomater Adv; 2022 May; 136():212798. PubMed ID: 35929326
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
Li H; Song JH; Park JS; Han K
Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749
[TBL] [Abstract][Full Text] [Related]
16. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
17. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
18. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Shao Y; Yang L; Han HK
Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
20. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.
Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W
Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
